Heron Therapeutics Inc HRTX

US Biotechnology

$0.38 ▲ +2.56% (+$0.01)

🔥 High Short Interest

Open $0.38

Prev Close $0.37

Day Range $0.34 – $0.41

52W Range $0.26 – $1.58

Market Cap $70.36M

Beta 1.64

EPS (TTM) $-0.19

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	1987-08-26
Shares Out.	189,850,000
Website	herontx.com ↗
Phone	13026365400
Employees	128
Revenue	$37.7M
Gross Profit	$26.1M
Net Income	-$5.5M
Free Cash Flow	-$12.1M
Total Assets	$252.3M
Total Liabilities	$245.4M
Equity	$6.9M

About Heron Therapeutics Inc

Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Heron Therapeutics Inc is a publicly traded company under the ticker symbol HRTX on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.